246 related articles for article (PubMed ID: 25408490)
1. Adjusting relative survival estimates for cancer mortality in the general population.
Ellison LF
Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
[TBL] [Abstract][Full Text] [Related]
2. Estimating relative survival for cancer: An analysis of bias introduced by outdated life tables.
Ellison LF
Health Rep; 2014 Feb; 25(2):13-9. PubMed ID: 24567246
[TBL] [Abstract][Full Text] [Related]
3. Leading cancers--changes in five-year relative survival.
Ellison LF; Gibbons L
Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
[TBL] [Abstract][Full Text] [Related]
4. Cancer survival in five continents: a worldwide population-based study (CONCORD).
Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
[TBL] [Abstract][Full Text] [Related]
5. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
Engholm G; Gislum M; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
[TBL] [Abstract][Full Text] [Related]
6. The impact of state-specific life tables on relative survival.
Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235
[TBL] [Abstract][Full Text] [Related]
7. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
8. Estimating expected survival probabilities for relative survival analysis--exploring the impact of including cancer patient mortality in the calculations.
Talbäck M; Dickman PW
Eur J Cancer; 2011 Nov; 47(17):2626-32. PubMed ID: 21924892
[TBL] [Abstract][Full Text] [Related]
9. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
10. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
Singer RB
J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
[TBL] [Abstract][Full Text] [Related]
11. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study.
Withrow DR; Pole JD; Nishri ED; Tjepkema M; Marrett LD
Popul Health Metr; 2017 Jul; 15(1):24. PubMed ID: 28673318
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. Differences in cancer survival in Canada by sex.
Ellison LF
Health Rep; 2016 Apr; 27(4):19-27. PubMed ID: 27096620
[TBL] [Abstract][Full Text] [Related]
14. Bias in relative survival methods when using incorrect life-tables: lung and bladder cancer by smoking status and ethnicity in New Zealand.
Blakely T; Soeberg M; Carter K; Costilla R; Atkinson J; Sarfati D
Int J Cancer; 2012 Sep; 131(6):E974-82. PubMed ID: 22419246
[TBL] [Abstract][Full Text] [Related]
15. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
Brenner H; Jansen L
J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
[TBL] [Abstract][Full Text] [Related]
16. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
17. Survival from cancer--up-to-date predictions using period analysis.
Ellison LF; Gibbons L
Health Rep; 2006 May; 17(2):19-30. PubMed ID: 16716033
[TBL] [Abstract][Full Text] [Related]
18. Stage at diagnosis and early mortality from cancer in England.
McPhail S; Johnson S; Greenberg D; Peake M; Rous B
Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
[TBL] [Abstract][Full Text] [Related]
19. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
20. Adjusting for the proportion of cancer deaths in the general population when using relative survival: a sensitivity analysis.
Hinchliffe SR; Dickman PW; Lambert PC
Cancer Epidemiol; 2012 Apr; 36(2):148-52. PubMed ID: 22000329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
